Neurotensin Analogues Containing Cyclic Surrogates of Tyrosine at Position 11 Improve NTS2 Selectivity Leading to Analgesia without Hypotension and Hypothermia.


Journal

ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337

Informations de publication

Date de publication:
20 11 2019
Historique:
pubmed: 8 10 2019
medline: 26 9 2020
entrez: 8 10 2019
Statut: ppublish

Résumé

Neurotensin (NT) exerts its analgesic effects through activation of the G protein-coupled receptors NTS1 and NTS2. This opioid-independent antinociception represents a potential alternative for pain management. While activation of NTS1 also induces a drop in blood pressure and body temperature, NTS2 appears to be an analgesic target free of these adverse effects. Here, we report modifications of NT at Tyr

Identifiants

pubmed: 31589400
doi: 10.1021/acschemneuro.9b00390
doi:

Substances chimiques

Ntsr2 protein, rat 0
Receptors, Neurotensin 0
Neurotensin 39379-15-2
Tyrosine 42HK56048U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4535-4544

Subventions

Organisme : Canadian Institute of Health Research
ID : FDN-148413
Pays : International
Organisme : Canadian Institute of Health Research
ID : MOP-123399
Pays : International
Organisme : Canadian Institute of Health Research
ID : MOP-136871
Pays : International

Auteurs

Emilie Eiselt (E)

Département de pharmacologie et physiologie, Institut de pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de médecine et des sciences de la santé , Université de Sherbrooke , Sherbrooke , Québec J1H 5H4 , Canada.

Simon Gonzalez (S)

Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry , Vrije Universiteit Brussel , Pleinlaan 2 , Brussels 1050 , Belgium.

Charlotte Martin (C)

Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry , Vrije Universiteit Brussel , Pleinlaan 2 , Brussels 1050 , Belgium.

Magali Chartier (M)

Département de pharmacologie et physiologie, Institut de pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de médecine et des sciences de la santé , Université de Sherbrooke , Sherbrooke , Québec J1H 5H4 , Canada.

Cecilia Betti (C)

Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry , Vrije Universiteit Brussel , Pleinlaan 2 , Brussels 1050 , Belgium.

Jean-Michel Longpré (JM)

Département de pharmacologie et physiologie, Institut de pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de médecine et des sciences de la santé , Université de Sherbrooke , Sherbrooke , Québec J1H 5H4 , Canada.

Florine Cavelier (F)

Institut des Biomolécules Max Mousseron, IBMM, UMR 5247, CNRS, Université de Montpellier, ENSCM , Place Eugène Bataillon , 34095 Montpellier Cedex 5, France.

Dirk Tourwé (D)

Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry , Vrije Universiteit Brussel , Pleinlaan 2 , Brussels 1050 , Belgium.

Louis Gendron (L)

Département de pharmacologie et physiologie, Institut de pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de médecine et des sciences de la santé , Université de Sherbrooke , Sherbrooke , Québec J1H 5H4 , Canada.

Steven Ballet (S)

Research Group of Organic Chemistry, Departments of Bioengineering Sciences and Chemistry , Vrije Universiteit Brussel , Pleinlaan 2 , Brussels 1050 , Belgium.

Philippe Sarret (P)

Département de pharmacologie et physiologie, Institut de pharmacologie de Sherbrooke, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Faculté de médecine et des sciences de la santé , Université de Sherbrooke , Sherbrooke , Québec J1H 5H4 , Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH